Analysis of clinical features and survival comparing early-onset and late-onset lung cancer across a large multicenter Chinese cohort, focusing on demographics and outcomes.
Key Takeaways
- Total of 6,883 lung cancer patients were included in the final analysis
- Compared with the LOLC group, the EOLC group had more females and never-smokers
- Lung cancer was the leading cause of cancer incidence and mortality in 2022